ACR disagrees with European recommendation on gadolinium; European decision will be reviewed
The American College of Radiology (ACR) Committee on Drugs and Contrast Media has disagreed with the recently published recommendation by the European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) to withdraw four MRI contrast agents. gadolinium-based products (GBCAs) on the market. The ACR committee said that, … Continue lendo